High‐quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID‐19-Reference-Cited by-同舟云学术

High‐quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID‐19

Published:2022-08 Issue:12 Volume:36 Page:4295-4298
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Huang Nan¹^ORCID,Li Saichao²

Affiliation:

1. Cerui Consulting Firm Shanghai China

2. Department of Health Technologies Yidu Cloud Technology (Shanghai) Inc Shanghai China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7574

Reference22 articles.

1. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening

2. Traditional and complementary medicine during COVID ‐19 pandemic

3. Goh B. &Liu R.(2022).China relies on traditional medicine to fight COVID surge in Shanghai. Reuters.https://www.reuters.com/world/china/china-relies-traditional-medicine-fight-covid-surge-shanghai-2022-04-06/

4. Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial

5. Impact of Drug Metabolism/Pharmacokinetics and its Relevance Considering Traditional Medicine-based Anti-COVID-19 Drug Research

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Lianhua Qingwen capsules on the positive rate of COVID-19 close contacts: A retrospective analysis of a large-scale population-based cohort study;Phytomedicine;2023-04

2. An adventure from a work in progress: Challenges and opportunities of pharmacophylogeny in combat against COVID‐19;Phytotherapy Research;2023-01-27

3. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies;Acta Pharmacologica Sinica;2022-10-17